A pharmaceutical company prevailed in additional patent infringement abbreviated new drug application (ANDA) litigation related to one of its products. Alison Baldwin led the litigation team that represented the pharmaceutical company in the matter, succeeding both in district court and on appeal.
Pharmaceutical Company Again Protects Product in ANDA Litigation
Lead Contacts
